Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years
Completed
Conditions studied: Human Papillomavirus (HPV)
In brief
The objectives of this study are: 1. to determine the degree of understanding and perceived risks for human papillomavirus (HPV) disease, to examine and assess attitudes for personal use of HPV vaccine and identify potential barriers to HPV vaccine access and utilization in a population of young men who have sex with men (MSM) (under 26 years of age)and in parents of boys aged 9 to 18 years 2. to determine HPV vaccine acceptance and predictors of acceptance in a population of young MSM and in patients of boys ages 9 to 18 years 3. to develop strategies to overcome potential barriers to vaccination and improve vaccine access and utilization via development of targeted educational initiatives.
Key facts
- Study ID
- NCT01197079
- Run by
- Ann & Robert H Lurie Children's Hospital of Chicago
- People needed
- 500
- Starts
- 2010-08-01
- Expected to finish
- 2016-12-01
- Last updated by the study team
- 2025-03-28
Who can join
Age: 9 and older, up to 26. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- MSM group - under age 26 years
- Parent group - parent of boy(s) ages 9 to 18 years
You may not qualify if…
- MSM group - previous receipt of HPV vaccine
- Parent group - previous receipt of HPV vaccine by male child
Where it is running
- Pediatric Private practice — Chicago, Illinois, United States
- Children's Memorial Hospital Uptown Clinic — Chicago, Illinois, United States
- Pediatric Private Practice — Chicago, Illinois, United States
- Erie Family Health Clinic — Chicago, Illinois, United States
- Howard Brown Health Center — Chicago, Illinois, United States
- Private pediatric practice — Evanston, Illinois, United States
- Pediatric Private practice — Evanston, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.